Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Metabolic syndrome (MetS) is a constellation of cardiometabolic predictor variables that when presented in tandem increases the risk of cardiovascular disease (CVD) and insulin resistance [1,2]. The prevalence of this classification affects approximately 1 in 3 adults in the United States [3]. Due to the high prevalence of this syndrome, proper identification of persons with MetS is imperative in order to prevent and/or modify the multiple predictor variables associated with CVD related morbidity and mortality as well as its high healthcare costs [1,2,4,5]. Furthermore, utilization of pathways for MetS classification could guide health education professional interventions before the onset of related morbidity and mortality
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi